Article No
BE0281-50MG
InVivoMAb anti-human CD19
InVivoMAb anti-human CD19
Antibodies Primary
Specifications
| MW | 150 kDa |
| Application | FA, FC, IF |
| Article No | BE0281-50MG |
| Country Availability | SE, FI, DK, NO, EE, LV, LT |
| Clone | 4G7 |
| Clone Type | monoclonal |
| Concentration | 4-11 mg/ml |
| Conjugation | Unconjugated |
| Description | InVivoMAb anti-human CD19 |
| Supplier | BioXCell |
| Endotoxin | <2EU/mg (<0.002EU/µg), Determined by LAL gel clotting assay|InVivoMAb |
| Immunogen | Human chronic lymphocytic leukemia (CLL) cells |
| Isotype | IgG1 |
| Keywords | In Vivo |
| Alias Names | In Vivo, bulk size |
| Product Type | Antibodies Primary |
| Purity | >95% |
| Shipping Information | BLUE ICE |
| Size | 50 mg |
| Source / Host | mouse |
| Species Reactivity | human |
| Storage | 4°C |
| Product Page Updated | 2024-03-25T10:15:09.827Z |
